Cited by

• Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma.

  Kurai J, Chikumi H, Hashimoto K, Takata M, Sako T, Yamaguchi K, Kinoshita N, Watanabe M, Touge H, Makino H, Igishi T, Hamada H, Yano S, Shimizu E. Kurai J, et al. Int J Oncol. 2012 Nov;41(5):1610-8. doi: 10.3892/ijo.2012.1607. Epub 2012 Aug 24. Int J Oncol. 2012. PMID: 22922885 Free PMC article.
• Somatomedins in tumour cyst fluid, cerebrospinal fluid, and tumour cytosol in patients with glial tumours.

  Prisell P, Persson L, Boethius J, Sara V. Prisell P, et al. Acta Neurochir (Wien). 1987;89(1-2):48-52. doi: 10.1007/BF01406667. Acta Neurochir (Wien). 1987. PMID: 3434342
• Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines.

  Brown KD, Blakeley DM, Roberts P, Avery RJ. Brown KD, et al. Biochem J. 1985 Jul 1;229(1):119-25. doi: 10.1042/bj2290119. Biochem J. 1985. PMID: 2994627 Free PMC article.
• Coordinated regulation by iron of the synthesis of two transformation-sensitive membrane proteins in NRK cells.

  Fernandez-Pol JA. Fernandez-Pol JA. Biol Trace Elem Res. 1979 Jun;1(2):157-68. doi: 10.1007/BF02821711. Biol Trace Elem Res. 1979. PMID: 24277070
• Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster.

  Madhukar BV, Brewster DW, Matsumura F. Madhukar BV, et al. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7407-11. doi: 10.1073/pnas.81.23.7407. Proc Natl Acad Sci U S A. 1984. PMID: 6095293 Free PMC article.